131I-mIBG treatment dosimetry: dependence on the fitting expression and the role of biodosimetry

被引：0
|
作者：
Torres-Espallardo, I. [1 ]
Balaguer, J. [1 ]
Montoro, A. [1 ]
Sebastian, N. [1 ]
Loaiza, J. [1 ]
Olivas, C. [1 ]
Bautista, J. [1 ]
Adria, M. [1 ]
Ibanez, B. [1 ]
Pascual, V. [1 ]
Campayo, J. [1 ]
Villaescusa, J. [1 ]
Canete, A. [1 ]
Castel, V. [1 ]
Bello, P. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP496
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [1] Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG
    Sudbrock, F.
    Eschner, W.
    Schmidt, M.
    Simon, T.
    Hero, B.
    Schicha, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (06): : 254 - 261
  • [2] Dosimetry for Repeated 131I-mIBG Therapy of Phaeochromoblastoma
    Happel, C.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Plastowez, W.
    Diener, J.
    Kranert, W. T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [3] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [4] 131I-MIBG therapy: Dosimetry estimations in neuroendocrine patients.
    Castellani, M. R.
    Chiesa, C.
    Luksch, R.
    Aliberti, A.
    Maccauro, M.
    Seregni, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S317 - S317
  • [5] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [6] Dosimetry in 131I-MIBG therapy: moving toward personalized medicine
    Chiesa, C.
    Castellani, R.
    Mira, M.
    Lorenzoni, A.
    Flux, G. D.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (02): : 161 - 170
  • [7] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [8] Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy 123I-MIBG Versus Posttherapy 131I-MIBG Imaging
    Pandit-Taskar, Neeta
    Zanzonico, Pat
    Hilden, Patrick
    Ostrovnaya, Irina
    Carrasquillo, Jorge A.
    Modak, Shakeel
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 741 - 748
  • [9] Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans
    Myriam Monsieurs
    Boudewijn Brans
    Klaus Bacher
    Rudi Dierckx
    Hubert Thierens
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 1581 - 1587
  • [10] Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours
    Monsieurs, MA
    Thierens, HM
    Vral, A
    Brans, B
    De Ridder, L
    Dierckx, RA
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (04) : 367 - 374
12345